Press release
Fibrotic Diseases Treatment Market Key Players Analysis - AbbVie Inc., Gilead Sciences, Inc., KITHER BIOTECH S.R.L., BioMX.
Fibrotic Diseases Treatment Market
According to the latest research by InsightAce Analytic, the Fibrotic Diseases Treatment Market is valued at US$ 3.57 billion in 2023, and it is expected to reach US$ 5.40 billion by 2031, with a CAGR of 5.53% during the forecast period of 2024-2031.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2876
Fibrosis is defined by the pathological accumulation of fibrous connective tissue, often arising from injury, tissue damage, or chronic disease processes. While this mechanism can be part of normal wound healing, excessive fibrotic tissue formation frequently affects organs such as the skin, liver, kidneys, and lungs, leading to impaired organ function. The global fibrosis treatment market is expected to witness sustained growth, driven by the rising incidence of fibrotic disorders and the increasing prevalence of associated risk factors, including smoking.
Furthermore, ongoing advancements in therapeutic technologies, coupled with growing healthcare expenditures in both developed and emerging markets, are enhancing manufacturers' ability to develop and commercialize innovative treatment solutions. These dynamics are projected to create favorable conditions for market expansion and support competitive differentiation across the industry.
List of Prominent Players in the Fibrotic Diseases Treatment Market:
• AbbVie Inc.
• Gilead Sciences, Inc.
• KITHER BIOTECH S.R.L.
• BioMX
• Verona Pharma plc
• Genentech, Inc.
• C.H. Boehringer Ingelheim International GmbH
• Redx Pharma Plc
• Alpine Immune Sciences
• Teva Pharmaceutical Industries Ltd.
• Sandoz International GmbH
• Camber Pharmaceuticals, Inc.
• Bristol-Myers Squibb Company
• BellBrook Labs
• Enveda
• Intercept Pharmaceuticals, Inc.
• Pharmaxis Ltd
• Accord Healthcare
• Other Market Players
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04
Market Dynamics
Drivers:
The global rise in fibrotic disorders, particularly those linked to aging and obesity, represents a growing public health and socioeconomic challenge, serving as a primary driver for the expansion of the fibrotic disease treatment market. The increasing prevalence of conditions such as idiopathic pulmonary fibrosis (IPF) has notably heightened demand for therapies including nintedanib and pirfenidone.
Additionally, persistent cigarette smoking continues to exacerbate fibrotic conditions, as tobacco smoke generates reactive oxygen and nitrogen species that promote inflammation and tissue fibrosis. These trends underscore the urgent need for innovative treatment strategies, including smoking cessation interventions, further supporting market growth.
Challenges:
High treatment costs remain a significant constraint on market expansion, driven by both the rising incidence of fibrotic diseases and the escalating prices of prescription therapies and medical technologies. While advancements in treatment modalities have improved clinical outcomes, they have simultaneously increased healthcare expenditures, limiting patient access in cost-sensitive regions.
In developing markets, the effective diagnosis and management of fibrotic conditions such as IPF are hampered by limited availability of diagnostic tools-including imaging technologies and pulmonary function testing-as well as the absence of reliable biomarkers and underdeveloped healthcare infrastructure, restricting timely intervention and market penetration.
Regional Trends:
North America is anticipated to retain a dominant position in the fibrotic disease treatment market, supported by an aging demographic and the high prevalence of fibrotic disorders. The presence of leading pharmaceutical and biotechnology companies in the region fosters innovation and accelerates the introduction of advanced therapies.
Conversely, the Asia-Pacific market is projected to experience rapid growth, driven by improvements in healthcare infrastructure, technological advancements in diagnostics and treatment, and increased efforts to address unmet medical needs. These factors are enhancing patient access to effective therapies and are expected to significantly strengthen the region's contribution to the global fibrotic disease treatment market.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2876
Recent Developments:
• In Oct 2022, AbbVie declared the acquisition of D.J.S. Antibodies Ltd. D.J.S.'s primary program is DJS-002, a prospective first-in-class lysophosphatidic acid (L.P.A.) receptor 1 (LPAR1) antagonist antibody now undergoing experimental preclinical research for the treatment of Idiopathic Pulmonary Fibrosis (I.P.F.) and other fibrotic disorders. Idiopathic pulmonary fibrosis (I.P.F.) is a severe, high-mortality condition characterized by fibrotic lung scarring and continues to represent a significant unmet medical need.
Segmentation of Fibrotic Diseases Treatment Market-
By Treatment-
• Medication
• Organ Transplantation
• Oxygen Therapy
• Others
By Application-
• Idiopathic Pulmonary Fibrosis
• Hepatic Cirrhosis
• Renal Fibrosis
• Cutaneous Fibrosis
• Others
By End User-
• Hospitals
• Specialty Clinics
• Academic and Research Institutes
• Others
By Distribution Channel-
• Hospital Pharmacy
• Retail Pharmacy
• Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa
Read Overview Report- https://www.insightaceanalytic.com/report/fibrotic-diseases-treatment-market/2876
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Fibrotic Diseases Treatment Market Key Players Analysis - AbbVie Inc., Gilead Sciences, Inc., KITHER BIOTECH S.R.L., BioMX. here
News-ID: 4171442 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Green Technology and Sustainability Market Top Companies Study - Xylem, Wolters …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Green Technology and Sustainability Market"-, By Component (Solutions & Services), By Deployment (Cloud & On-Premise), By Enterprise Type (Large Enterprise and SMEs), By Implemented Technology (Internet of Things, AI & Analytics, Digital Twin, Cloud Computing, Blockchain), By Application (Air & Water Pollution Monitoring, Carbon Footprint Management, Crop Monitoring, Fire Detection, Forest Monitoring, Green Building, Soil Condition…
Electric Powertrain Market Key Players Analysis - Sigma Powertrain, Inc., Contin …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Electric Powertrain Market"-, By Integration Type (Integrated & Non-integrated), Component (Motor, Battery, BMS, Controller, PDM, Inverter/Converter, On-Board Charger), Propulsion (BEV, PHEV), Vehicle Type (PC & LCV), and Global Forecasts, 2024-2031 And Segment Revenue and Forecast To 2031."
The Electric Powertrain Market is estimated to reach over USD 301.6 billion by 2031, exhibiting a CAGR of 17.1%…
Smart City Platform Market Top Players - IBM, Siemens, Cisco, Hitachi, Microsoft …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Smart City Platform Market"-, By Offering (Platforms (Connectivity Management, Integration, Device Management, Security Platforms, Data Management Platforms) and Services (Professional Services, Consulting & Architecture Designing, Infrastructure Monitoring & Management, Deployment & Training, Managed Services)), By Delivery Model (Offshore, Hybrid, On-site), By Application (Smart Transportation, Public Safety, Smart Energy & Utility, Infrastructure Management, Citizen Engagement),, and Global…
Oral Proteins and Peptides Market Key Players Analysis - AstraZeneca, Biocon Chi …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Oral Proteins and Peptides Market"-, By Type of Target Disease Indication (Acromegaly, Celiac Disease, Chronic Idiopathic Constipation, Enteric Hyperoxaluria, Inflammatory Bowel Disease, and Type II Diabetes), Type of Molecule (Protein and Peptide), Type of Biological Target (GC-C, Insulin Receptor, Oxalate and others), Type of Mechanism of Action (Receptor Stimulation, Substrate Degradation and Others), and Global Forecasts,…
More Releases for Treatment
Trigeminal Neuralgia Treatment Market Size, Trigeminal Neuralgia Treatment Marke …
Trigeminal Neuralgia Treatment Market Dynamics are clarified by an in-depth review of facts on current and emerging trends. To understand a resource, the paper uses Porter's five forces to examine the importance of numerous qualities such as understanding of suppliers and customers, dangers provided by various agents, competitive strength, and promising new businesses. precious. Furthermore, the study covers numerous firms' Trigeminal Neuralgia Treatment research data, benefit, gross margin, worldwide market…
Medical Tourism Market Report by Treatment Type (Dental Treatment, Cosmetic Trea …
The global medical tourism market accounted for $104.68 billion in 2019, and is projected to reach $273.72 billion by 2027, registering a CAGR of 12.8% from 2019 to 2027 in terms of value.
View Full Report: https://reports.valuates.com/market-reports/ALLI-Auto-0P310/medical-tourism
In terms of volume, the global medical tourism market accounted for 23,042.90 thousand patients in 2019, and is projected to reach 70,358.61 thousand patients by 2027, registering a CAGR of 15.0% from 2019 to…
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot
In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products.
Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,…
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot
In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products.
Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,…
Medical Tourism Market by Treatment Type (Dental Treatment, Cosmetic Treatment, …
Medical Tourism Market Overview:
The global medical tourism market was valued at $53,768 million in 2017, and is estimated to reach at $143,461 million by 2025, registering a CAGR of 12.9% from 2018 to 2025.
Organized travel across international borders to avail medical treatment of some form, which may or may not be available in the travelers home country is defined as medical tourism. Medical tourists travel abroad for the maintenance, enhancement,…
Substance Use Disorder Treatment Market By Type (Alcohol abuse treatment, Nicoti …
According to World Health Organization (WHO), the leading cause of disability around the world is not a physical disease, but a serious mood disorder known as depression. Around 350 million people suffer from depression worldwide, and that only about 50% of these individuals will ever receive treatment. According to Anxiety and Depression Association of America, in the U.S., over 15 million adults experience an episode of clinical depression in any…
